Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Case Presentation
  • Published:

Perinatal/Neonatal Case Presentation

Transient hypertrophic pyloric stenosis due to prostoglandin infusion

Abstract

Prostaglandin E1 (PGE1) is widely used in ductus-dependant congenital heart disease to maintain the patency of ductus. Hypertrophic pyloric stenosis (HPS) due to gastric mucosal proliferation is a rare complication of prolonged PGE infusion. A male newborn who developed HPS during PGE1 infusion is presented to discuss the clinical features and treatment modalities of PGE-related transient HPS. The boy was 2500 g and born at 35 weeks of gestation from a 23-year-old mother. He was admitted to neonatal intensive care with breathing difficulty and cyanosis. His echocardiography revealed pulmonary atresia, ventricular septal defect and major aorta-pulmonary collateral (MAPCA). PGE infusion with a dose of 0.05 mcg kg–1 was initiated. At the 8th day of infusion, he developed non-billous vomiting. Ultrasonographic evaluation revealed 1.9 cm length of pyloric channel and 0.5 cm of wall thickness on 11th day and diagnosed as HPS. On 42th postnatal day, he underwent MAPCA closure, right modified Blalock-Taussi shunt and repair of pulmonary artery bifurcation with bovine patch. PGE infusion was stopped and enteral nutrition was started on 8th postoperative day. Control ultrasonography on 12th postoperative day revealed normal pyloric channel length (0.9 cm) and wall thickness (0.3 cm). Prolonged use of PGE infusion in neonates with congenital heart disease may cause transient HPS. The clinical and radiological features of HPS relieves after stopping PGE infusion. It should be kept in mind that HPS due to PGE infusion can be transient and pyloromyotomy should be kept for patients with persistent findings.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

Evdokia Dimitriadis, Daniel L. Rolnik, … Ellen Menkhorst

References

  1. Kosiak W, Sweiton D, Fryze I, Aleszewicz-Baranowska J, Duklas M, Chojnicki M . Gastric outlet obstruction due to an iatrogenic cause in a neonatal period- Report of two cases. Ultraschall Med 2008; 29: 401–403.

    Article  Google Scholar 

  2. Lewis AB, Freed MD, Heymann MA, Roehl SL, Kensey RC . Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation 1981; 64: 893–898.

    Article  CAS  Google Scholar 

  3. Peled N, Dagan O, Bayn P, Silver MM, Barker G, Hellmann J et al. Gastric-outlet obstruction induced by prostaglandin therapy in neonates. N Engl J Med 1992; 327: 505–510.

    Article  CAS  Google Scholar 

  4. Shinohara K, Shimizu T, Igarashi J, Yamashiro Y, Miyano T . Correlation of prostaglandin E2 production and gastric acid secretion in infants with hypertrophic pyloric stenosis. J Pediatr Surg 1998; 33: 1483–1485.

    Article  CAS  Google Scholar 

  5. Callahan MJ, McCauley RG, Patel H, Hijazi ZM . The development of hypertrophic pyloric stenosis in a patient with prostaglandin-induced foveolar hyperplasia. Pediatr Radiol 1999; 29: 748–751.

    Article  CAS  Google Scholar 

  6. Lacher M, Schneider K, Dalla Pozza R, Schweinitz D . Gastric outlet obstruction after long-term prostaglandin administration mimicking hypertrophic pyloric stenosis. Eur J Pediatr Surg 2007; 17: 362–364.

    Article  CAS  Google Scholar 

  7. Perme T, Mali S, Vidmar I, Gvardijančič D, Blumauer R, Mishaly D et al. Prolonged prostaglandin E1 therapy in a neonate with pulmonary atresia and ventricular septal defect and the development of antral foveolar hyperplasia and hypertrophic pyloric stenosis. Ups J Med Sci 2013; 118: 138–142.

    Article  Google Scholar 

  8. Forman HP, Leonidas JC, Kronfeld GD . A rational approach to the diagnosis of hypertrophic pyloric stenosis: do the results match the claims? J Pediatr Surg 1990; 25: 262–266.

    Article  CAS  Google Scholar 

  9. Kriss VM, Desai NS . Relation of gastric distention to prostaglandin therapy in neonates. Radiology 1993; 203: 219–221.

    Article  Google Scholar 

  10. Mercado-Deane MG, Burton EM, Brawley AV, Hatley R . Prostaglandin induced foveolar hyperplasia simulating pyloric stenosis in an infant with cyanotic heart disease. Pediatr Radiol 1994; 24: 45–46.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T Soyer.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Soyer, T., Yalcin, S., Bozkaya, D. et al. Transient hypertrophic pyloric stenosis due to prostoglandin infusion. J Perinatol 34, 800–801 (2014). https://doi.org/10.1038/jp.2014.101

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2014.101

This article is cited by

Search

Quick links